Wojciech Biernat
Overview
Explore the profile of Wojciech Biernat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
2371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunc M, Skrzypkowska P, Peksa R, Biernat W
Clin Exp Metastasis
. 2025 Jan;
42(2):14.
PMID: 39890663
Tumor-to-tumor metastasis is an exceedingly rare phenomenon where secondary deposits of a tumor develops in another one. Our systematic review and meta-analysis aims to uncover and analyze reported cases to...
2.
Speel E, Dafni U, Thunnissen E, Ruschoff J, OBrien C, Kowalski J, et al.
Lung Cancer
. 2024 Jul;
194:107860.
PMID: 39002492
Background: ROS1 fusion is a relatively low prevalence (0.6-2.0%) but targetable driver in lung adenocarcinoma (LUAD). Robust and low-cost tests, such as immunohistochemistry (IHC), are desirable to screen for patients...
3.
Ciarka A, Kunc M, Popeda M, Lacko A, Radecka B, Braun M, et al.
Contemp Oncol (Pozn)
. 2024 May;
28(1):75-83.
PMID: 38800535
Introduction: This study aimed to evaluate the impact of tumour-infiltrating lymphocytes (TILs) on the expression of immune-related genes and prognosis in single hormone receptor-positive breast cancer. Material and methods: Tumour-infiltrating...
4.
Wojcik M, Juhas U, Mohammadi E, Mattisson J, Drezek-Chyla K, Rychlicka-Buniowska E, et al.
Sci Rep
. 2024 Apr;
14(1):9458.
PMID: 38658633
Male sex is a risk factor for colorectal cancer (CRC) with higher illness burden and earlier onset. Thus, we hypothesized that loss of chromosome Y (LOY) in the tumor micro-environment...
5.
Inaguma S, Wang C, Ito S, Ueki A, Lasota J, Czapiewski P, et al.
Pathobiology
. 2024 Mar;
91(5):313-325.
PMID: 38527431
Introduction: Over the past decade, classifications using immune cell infiltration have been applied to many types of tumors; however, mesotheliomas have been less frequently evaluated. Methods: In this study, 60...
6.
Stankowska W, Sarkisyan D, Bruhn-Olszewska B, Duzowska K, Bienkowski M, Jakalski M, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473323
Bladder urothelial carcinoma (BLCA) is the 10th most common cancer with a low survival rate and strong male bias. We studied the field cancerization in BLCA using multi-sample- and multi-tissue-per-patient...
7.
Stein T, Robak T, Biernat W, Robak E
J Clin Med
. 2024 Feb;
13(3).
PMID: 38337516
One of the most common subgroups of cutaneous T-cell lymphomas is that of primary cutaneous CD30-positive lymphoproliferative disorders. The group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large cell...
8.
Skrzypkowska P, Kunc M, Biernat W
Contemp Oncol (Pozn)
. 2023 Oct;
27(2):118-121.
PMID: 37794991
Melanomas are known for their diverse morphological features, presenting a diagnostic challenge for pathologists. Uncommon variations of melanoma can exhibit distinct cytological and histomorphological characteristics, including ganglioneuroblastic differentiation. However, this...
9.
Gorczynski A, Miszewski K, Gager Y, Koch S, Potschke J, Ugrinovski D, et al.
Cancer Biomark
. 2023 Jul;
38(1):17-26.
PMID: 37522200
Background: ALK receptor tyrosine kinase (ALK) aberrations have an established role in pathogenesis of many neoplasms, but their clinical significance in high grade serous ovarian carcinoma (HGSOC) is unclear. Objective:...
10.
Zurowska A, Peksa R, Bienkowski M, Skrobisz K, Sowa M, Matuszewski M, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509343
Background: Multiparametric prostate MRI (mpMRI) is gaining wider recommendations for diagnosing and following up on prostate cancer. However, despite the high accuracy of mpMRI, false positive and false negative results...